To examine further the effects of FOXO3a activation on drug resistance in breast cancer cells, the MDA-MB-231-FOXO3a(A3):ER cells were treated with either the vehicle (ethanol) or 4-OHT and subjected to doxorubicin treatment. The gene discussed is FOXO3; the disease is breast carcinoma.